Cargando…
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
BACKGROUND: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients reported in Germany based on the Brighton Collaboration (BC) case definition criteria for Thrombosis and Thrombocytopenia Syndrome (T...
Autores principales: | Thiele, Thomas, Weisser, Karin, Schönborn, Linda, Funk, Markus B., Weber, Gabriele, Greinacher, Andreas, Keller-Stanislawski, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645417/ https://www.ncbi.nlm.nih.gov/pubmed/34901912 http://dx.doi.org/10.1016/j.lanepe.2021.100270 |
Ejemplares similares
-
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021) -
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
por: Greinacher, Andreas, et al.
Publicado: (2021) -
Thrombus Distribution in Vaccine-induced Immune Thrombotic
Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Rogers, Priya, et al.
Publicado: (2022) -
Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
por: Boonyawat, Kochawan, et al.
Publicado: (2022) -
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2021)